As yet, there are limited small molecules inhibitors of HSP70 available; however, it would be interesting to combine HSP90 and HSP70 inhibitors that would target HSP90 and both HSC70 and HSP72 isoforms to enhance tumour response to these agents. Here, HSPA8 is linked to neoplasm.